While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
Academic rigor, journalistic flair
Articles on Cancer screening
Displaying 1 - 20 of 43 articles
From primary care to cancer screening and insurance coverage, gender-diverse people still face many hurdles to getting good medical care.
Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
There have been calls for Australia to follow the US and lower the age for screening, from the current starting age of 50. So should we follow suit?
Early detection of breast cancer is critical to improving chances of survival. But racial and ethnic minority patients systematically have delayed diagnoses that reduce the benefits of screening.
Many eligible Australians are not partaking in care to protect their health. Why?
There are currently no effective tests to screen for ovarian cancer. But that doesn’t mean there aren’t ways to recognize and prevent it.
Doctors don’t ‘check you for everything’, but are guided by what you personally would benefit from, based on your age and individual history.
The Affordable Care Act has allowed many preventive health services, including cancer screenings and vaccines, to be free of charge. But legal challenges may lead to costly repercussions for patients.
Only 6,000 women used self-collection in cervical screening between 2017 and 2019, out of about one million women eligible. We need to boost those numbers if we’re ever to eliminate cervical cancer.
Inuit living in their traditional territory must travel long distances — often with no personal support — for specialized health-care services like cancer care, obstetrics and dialysis.
I was motivated to improve the outcome for women with ovarian cancer by my experience as a junior doctor in London in 1985. But 36 years on, the results aren’t what we’d hoped.
Informed choice works better than coercion.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Automated decision making has been around in healthcare since the 1970s, and now radiology is the new frontline where AI is being deployed.
New tests may mean more people are diagnosed, but that doesn’t mean they’ll be helped by the label or the treatment. Here are five markers that overdiagnosis may be occuring.
As you age, your body deteriorates and your risk of disease and injury increases. Here’s a decade by decade guide to what you’re up against – and what you can do about it.
Labelling very low-risk conditions as cancers can cause unnecessary anxiety and lead to overtreatment.
Prostate cancer is the second deadliest cancer among men, but not all types of the disease are as deadly as others. That has led to confusion over screening. An expert explains why new guidelines make sense.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
Top contributors
-
Professor of Public Health, University of Sydney
-
Associate Professor in Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Emeritus Professor in Public Health, University of Sydney
-
Professor of Medicine, Bond University
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, The University of Western Australia
-
Emeritus Professor, Menzies Centre for Health Policy, University of Sydney
-
NHMRC Australia Fellow, The University of Melbourne
-
Professor of Public Health, Bond University
-
Lecturer in the School of Women's and Children's Health, UNSW Sydney
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Oliver Frank is a Friend of The Conversation.
Senior Research Fellow, Discipline of General Practice, and Specialist General Practitioner, University of Adelaide
-
Associate Professor, Bond University
-
Clinical Professorial Research Fellow, The University of Queensland
-
Postdoctoral research fellow, Deakin University
-
Researcher at Sydney Health Ethics, University of Sydney
